Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8⁺ T cells that induce GVHD without antileukemic effects|
|Other Titles:||Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8(+) T cells that induce GVHD without antileukemic effects|
|Citation:||Blood, 2015; 126(13):1609-1620|
|Publisher:||American Society of Hematology|
|Kate H. Gartlan, Kate A. Markey, Antiopi Varelias, Mark D. Bunting, Motoko Koyama, Rachel D. Kuns, Neil C. Raffelt, Stuart D. Olver, Katie E. Lineburg, Melody Cheong, Bianca E. Teal, Mary Lor, Iain Comerford, Michele W. L. Teng, Mark J. Smyth, James McCluskey, Jamie Rossjohn, Brigitta Stockinger, Glen M. Boyle, Steven W. Lane, Andrew D. Clouston, Shaun R. McColl, Kelli P. A. MacDonald, and Geoffrey R. Hill|
|Abstract:||IL-17-producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (SCT). Here we demonstrate that a distinct CD8(+) Tc17 population develops rapidly after SCT but fails to maintain lineage fidelity such that they are unrecognizable in the absence of a fate reporter. Tc17 differentiation is dependent on alloantigen presentation by host dendritic cells (DCs) together with IL-6. Tc17 cells express high levels of multiple prototypic lineage-defining transcription factors (eg, RORγt, T-bet) and cytokines (eg, IL-17A, IL-22, interferon-γ, granulocyte macrophage colony-stimulating factor, IL-13). Targeted depletion of Tc17 early after transplant protects from lethal acute GVHD; however, Tc17 cells are noncytolytic and fail to mediate graft-versus-leukemia (GVL) effects. Thus, the Tc17 differentiation program during GVHD culminates in a highly plastic, hyperinflammatory, poorly cytolytic effector population, which we term "inflammatory iTc17" (iTc17). Because iTc17 cells mediate GVHD without contributing to GVL, therapeutic inhibition of iTc17 development in a clinical setting represents an attractive approach for separating GVHD and GVL.|
|Rights:||© 2015 by The American Society of Hematology|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.